id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-N-0001-0138,FDA,FDA-2016-N-0001,"Advisory Committee; Gastrointestinal Drugs Advisory Committee, Renewal",Notice,Notice of Renewal,2018-03-27T04:00:00Z,2018,3,2018-03-27T04:00:00Z,,2018-03-27T12:52:53Z,2018-06063,0,0,09000064830544af
FDA-2016-N-0001-0137,FDA,FDA-2016-N-0001,Scientific Evidence Workshop Transcript 09082016,Other,Transcript(s),2017-08-24T04:00:00Z,2017,8,2017-08-24T04:00:00Z,,2017-08-24T20:34:57Z,,0,0,0900006482aba1ec
FDA-2016-N-0001-0136,FDA,FDA-2016-N-0001,"Transcript of Public Workshop on Identification and Characterization of Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products - February 9, 2017",Other,Transcript(s),2017-04-17T04:00:00Z,2017,4,2017-04-17T04:00:00Z,,2017-04-17T15:04:25Z,,0,0,0900006482559eba
FDA-2016-N-0001-0135,FDA,FDA-2016-N-0001,"Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop",Other,Transcript(s),2017-04-14T04:00:00Z,2017,4,2017-04-14T04:00:00Z,,2017-04-14T15:44:16Z,,0,0,09000064825564be
FDA-2016-N-0001-0134,FDA,FDA-2016-N-0001,"Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction",Notice,Correction,2017-03-20T04:00:00Z,2017,3,2017-03-20T04:00:00Z,,2017-03-20T13:22:31Z,2017-05417,0,0,090000648251314b
FDA-2016-N-0001-0133,FDA,FDA-2016-N-0001,"Transcript of Controlling the Progression of Myopia - Public Workshop, September 30, 2016",Other,Transcript(s),2017-02-06T05:00:00Z,2017,2,2017-02-06T05:00:00Z,,2017-02-06T16:21:16Z,,0,0,09000064824ad852
FDA-2016-N-0001-0132,FDA,FDA-2016-N-0001,Psychopharmacologic Drugs Advisory Committee; Cancellation,Notice,Meeting,2017-01-19T05:00:00Z,2017,1,2017-01-19T05:00:00Z,,2017-01-19T16:40:51Z,2017-01170,0,0,090000648248501f
FDA-2016-N-0001-0131,FDA,FDA-2016-N-0001,"Circulatory System Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting",Notice,Meeting,2017-01-09T05:00:00Z,2017,1,2017-01-09T05:00:00Z,,2017-01-09T15:25:39Z,2017-00143,0,0,0900006482452bf6
FDA-2016-N-0001-0130,FDA,FDA-2016-N-0001,"Advisory Committee; Technical Electronic Product Radiation Safety
Standards Committee, Renewal",Notice,Notice of Renewal,2017-01-04T05:00:00Z,2017,1,2017-01-04T05:00:00Z,,2017-01-04T14:20:13Z,2016-31847,0,0,0900006482449585
FDA-2016-N-0001-0129,FDA,FDA-2016-N-0001,"Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop",Notice,Public Meetings,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T14:11:28Z,2016-31628,0,0,090000648243d171
FDA-2016-N-0001-0128,FDA,FDA-2016-N-0001,Psychopharmacologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-12-27T05:00:00Z,2016,12,2016-12-27T05:00:00Z,,2016-12-27T13:46:42Z,2016-31144,0,0,09000064824373d0
FDA-2016-N-0001-0123,FDA,FDA-2016-N-0001,Meeting notes from Refurbishing Reconditioning Rebuilding Remarketing Remanufacturing and Servicing of Medical Devices Performed by Third Party Entities and Original Equipment Manufacturers Public Workshop held on October 27  28  2016 1,Other,Minutes,2016-12-09T05:00:00Z,2016,12,2016-12-09T05:00:00Z,,2016-12-09T14:50:18Z,,0,0,09000064823f4fdb
FDA-2016-N-0001-0124,FDA,FDA-2016-N-0001,Meeting notes on Refurbishing Reconditioning Rebuilding Remarketing Remanufacturing and Servicing of Medical Devices Performed by Third Party Entities and Original Equipment Manufacturers Public Workshop held on October 27  28  2016 2,Other,Minutes,2016-12-09T05:00:00Z,2016,12,2016-12-09T05:00:00Z,,2016-12-09T14:55:40Z,,0,0,09000064823f4fdf
FDA-2016-N-0001-0122,FDA,FDA-2016-N-0001,Request for Nominations on the Blood Products Advisory Committee,Notice,Request for Nominations,2016-11-25T05:00:00Z,2016,11,2016-11-25T05:00:00Z,,2016-11-25T14:43:35Z,2016-28306,0,0,09000064823beea4
FDA-2016-N-0001-0121,FDA,FDA-2016-N-0001,"Science Board to the Food and Drug Administration Advisory Committee;
Notice of Meeting",Notice,Meeting,2016-11-02T04:00:00Z,2016,11,2016-11-02T04:00:00Z,,2016-11-02T13:42:16Z,2016-26491,0,0,09000064823691fc
FDA-2016-N-0001-0120,FDA,FDA-2016-N-0001,"The Sentinel Post-Licensure Rapid Immunization Safety Monitoring
Program; Public Workshop; Correction",Notice,Correction,2016-10-26T04:00:00Z,2016,10,2016-10-26T04:00:00Z,,2016-10-26T16:19:38Z,2016-25853,0,0,090000648234d4ea
FDA-2016-N-0001-0119,FDA,FDA-2016-N-0001,"Request for Nominations for Voting Members on a Public Advisory
Committee; Food Advisory Committee",Notice,Request for Nominations,2016-10-21T04:00:00Z,2016,10,2016-10-21T04:00:00Z,,2016-10-21T13:43:10Z,2016-25497,0,0,0900006482330a19
FDA-2016-N-0001-0118,FDA,FDA-2016-N-0001,Substitutability of Generic Drugs: Perceptions and Reality; Public Workshop,Notice,Announcement,2016-10-17T04:00:00Z,2016,10,2016-10-17T04:00:00Z,,2016-10-17T12:39:28Z,2016-25004,0,0,0900006482303505
FDA-2016-N-0001-0117,FDA,FDA-2016-N-0001,"Advisory Committee; Antimicrobial Drugs Advisory Committee, Renewal",Notice,Renewals,2016-10-14T04:00:00Z,2016,10,2016-10-14T04:00:00Z,,2016-10-14T13:04:57Z,2016-24810,0,0,09000064822f7767
FDA-2016-N-0001-0116,FDA,FDA-2016-N-0001,"Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory 
Committee, Renewal",Notice,Renewals,2016-10-14T04:00:00Z,2016,10,2016-10-14T04:00:00Z,,2016-10-14T12:57:44Z,2016-24816,0,0,09000064822f7703
FDA-2016-N-0001-0114,FDA,FDA-2016-N-0001,"Request for Nominations for Voting Members for the Patient Engagement
Advisory Committee",Notice,Request for Nominations,2016-10-05T04:00:00Z,2016,10,2016-10-05T04:00:00Z,,2016-10-05T13:15:14Z,2016-24100,0,0,090000648229a001
FDA-2016-N-0001-0115,FDA,FDA-2016-N-0001,Pharmacy Compounding Advisory Committee; Notice of Meeting,Notice,Announcement,2016-10-05T04:00:00Z,2016,10,2016-10-05T04:00:00Z,,2016-10-05T13:31:54Z,2016-24085,0,0,090000648229a520
FDA-2016-N-0001-0113,FDA,FDA-2016-N-0001,"Bone, Reproductive and Urologic Drugs Advisory Committee; Notice of
Meeting",Notice,Meeting,2016-09-23T04:00:00Z,2016,9,2016-09-23T04:00:00Z,,2016-09-23T15:20:43Z,2016-22925,0,0,090000648225b093
FDA-2016-N-0001-0112,FDA,FDA-2016-N-0001,Technical Electronic Product Radiation Safety Standards Committee; Notice of Meeting,Notice,Meeting,2016-09-22T04:00:00Z,2016,9,2016-09-22T04:00:00Z,,2016-09-22T14:12:38Z,2016-22808,0,0,0900006482239ffd
FDA-2016-N-0001-0111,FDA,FDA-2016-N-0001,Risk Communication Advisory Committee; Notice of Meeting,Notice,Meeting,2016-09-20T04:00:00Z,2016,9,2016-09-20T04:00:00Z,,2016-09-20T13:39:01Z,2016-22553,0,0,090000648222d97f
FDA-2016-N-0001-0109,FDA,FDA-2016-N-0001,"Coordinated Development of Antimicrobial Drugs and Antimicrobial 
Susceptibility Test Devices",Notice,Announcement,2016-09-16T04:00:00Z,2016,9,2016-09-16T04:00:00Z,,2016-09-16T13:16:15Z,2016-22352,0,0,090000648221841e
FDA-2016-N-0001-0110,FDA,FDA-2016-N-0001,Menu Labeling Public Workshop; Public Meeting,Notice,Meeting,2016-09-16T04:00:00Z,2016,9,2016-09-16T04:00:00Z,,2016-09-16T13:29:28Z,2016-22337,0,0,0900006482218422
FDA-2016-N-0001-0108,FDA,FDA-2016-N-0001,Vaccines and Related Biological Products Advisory Committee; Cancellation,Notice,Meeting,2016-09-14T04:00:00Z,2016,9,2016-09-14T04:00:00Z,,2016-09-14T13:51:15Z,2016-22051,0,0,090000648220a1a0
FDA-2016-N-0001-0107,FDA,FDA-2016-N-0001,Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee,Notice,Advisory Committee,2016-09-12T04:00:00Z,2016,9,2016-09-12T04:00:00Z,,2016-09-12T15:25:29Z,2016-21819,0,0,09000064821f859d
FDA-2016-N-0001-0106,FDA,FDA-2016-N-0001,Science Advisory Board to the National Center for Toxicological Research Advisory Committee; Notice of Meeting,Notice,Meeting,2016-09-09T04:00:00Z,2016,9,2016-09-09T04:00:00Z,,2016-09-09T14:24:57Z,2016-21688,0,0,09000064821e7673
FDA-2016-N-0001-0105,FDA,FDA-2016-N-0001,"Blood Products Advisory Committee Advisory Committee; Notice of 
Meeting",Notice,Public Meetings,2016-09-09T04:00:00Z,2016,9,2016-09-09T04:00:00Z,,2016-09-09T14:17:28Z,2016-21687,0,0,09000064821e7573
FDA-2016-N-0001-0104,FDA,FDA-2016-N-0001,"Advisory Committee; Oncologic Drugs Advisory Committee, Renewal",Notice,Notice of Renewal,2016-09-08T04:00:00Z,2016,9,2016-09-08T04:00:00Z,,2016-09-08T13:39:25Z,2016-21550,0,0,09000064821e0f8c
FDA-2016-N-0001-0103,FDA,FDA-2016-N-0001,"Advisory Committee; Endocrinologic and Metabolic Drugs Advisory
Committee, Renewal",Notice,Notice of Renewal,2016-09-01T04:00:00Z,2016,9,2016-09-01T04:00:00Z,,2016-09-01T14:52:15Z,2016-21040,0,0,09000064821bd193
FDA-2016-N-0001-0101,FDA,FDA-2016-N-0001,"Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee,
Renewal",Notice,Notice of Renewal,2016-09-01T04:00:00Z,2016,9,2016-09-01T04:00:00Z,,2016-09-01T14:13:34Z,2016-21041,0,0,09000064821bd100
FDA-2016-N-0001-0102,FDA,FDA-2016-N-0001,"The Sentinel Post-Licensure Rapid Immunization Safety Monitoring
Program; Public Workshop",Notice,Public Meetings,2016-09-01T04:00:00Z,2016,9,2016-09-01T04:00:00Z,,2016-09-01T14:41:07Z,2016-21046,0,0,09000064821bd14d
FDA-2016-N-0001-0098,FDA,FDA-2016-N-0001,"FDA Small Business and Industry Assistance Regulatory Education for
Industry Fall Conference",Notice,Notice of Conference,2016-08-30T04:00:00Z,2016,8,2016-08-30T04:00:00Z,,2016-08-30T14:36:10Z,2016-20764,0,0,09000064821adfc5
FDA-2016-N-0001-0099,FDA,FDA-2016-N-0001,Antimicrobial Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-08-30T04:00:00Z,2016,8,2016-08-30T04:00:00Z,,2016-08-30T14:59:19Z,2016-20765,0,0,09000064821ae0c5
FDA-2016-N-0001-0100,FDA,FDA-2016-N-0001,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,Meeting,2016-08-30T04:00:00Z,2016,8,2016-08-30T04:00:00Z,,2016-08-30T15:04:30Z,2016-20763,0,0,09000064821ae14e
FDA-2016-N-0001-0097,FDA,FDA-2016-N-0001,National Mammography Quality Assurance Advisory Committee; Amendment of Notice,Notice,Announcement,2016-08-22T04:00:00Z,2016,8,2016-08-22T04:00:00Z,,2016-08-22T13:09:59Z,2016-19957,0,0,090000648218dc56
FDA-2016-N-0001-0095,FDA,FDA-2016-N-0001,Allergenic Products Advisory Committee; Notice of Meeting,Notice,Meeting,2016-08-15T04:00:00Z,2016,8,2016-08-15T04:00:00Z,,2016-08-15T16:36:12Z,2016-19338,0,0,09000064821757cb
FDA-2016-N-0001-0096,FDA,FDA-2016-N-0001,"Request for Nominations on the Tobacco Products Scientific Advisory
Committee",Notice,Request for Nominations,2016-08-15T04:00:00Z,2016,8,2016-08-15T04:00:00Z,,2016-08-15T16:40:25Z,2016-19312,0,0,0900006482175819
FDA-2016-N-0001-0094,FDA,FDA-2016-N-0001,"Facilitating Anti-Infective Drug Development for Neonates and Young
Infants; Notice of Public Workshop",Notice,Public Meetings,2016-08-15T04:00:00Z,2016,8,2016-08-15T04:00:00Z,,2016-08-15T16:30:22Z,2016-19336,0,0,09000064821755f5
FDA-2016-N-0001-0093,FDA,FDA-2016-N-0001,"Anesthetic and Analgesic Drug Products Advisory Committee and the
Drug Safety and Risk Management Advisory Committee; Notice of Meeting",Notice,Meeting,2016-08-10T04:00:00Z,2016,8,2016-08-10T04:00:00Z,,2016-08-10T14:11:43Z,2016-19005,0,0,0900006482164b77
FDA-2016-N-0001-0092,FDA,FDA-2016-N-0001,National Mammography Quality Assurance Advisory Committee; Notice of Meeting,Notice,Meeting,2016-08-05T04:00:00Z,2016,8,2016-08-05T04:00:00Z,,2016-08-05T13:44:36Z,2016-18592,0,0,0900006482158029
FDA-2016-N-0001-0090,FDA,FDA-2016-N-0001,Pediatric Master Protocols; Public Workshop,Notice,Meeting,2016-08-05T04:00:00Z,2016,8,2016-08-05T04:00:00Z,,2016-08-05T13:39:26Z,2016-18555,0,0,0900006482157e0b
FDA-2016-N-0001-0091,FDA,FDA-2016-N-0001,"Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting",Notice,Meeting,2016-08-05T04:00:00Z,2016,8,2016-08-05T04:00:00Z,,2016-08-05T13:42:28Z,2016-18560,0,0,0900006482157ef2
FDA-2016-N-0001-0089,FDA,FDA-2016-N-0001,Request for Nominations for Individuals and Consumer Organizations for Advisory Committees,Notice,Request for Nominations,2016-08-02T04:00:00Z,2016,8,2016-08-02T04:00:00Z,,2016-08-02T14:19:50Z,2016-18216,0,0,090000648214c51c
FDA-2016-N-0001-0087,FDA,FDA-2016-N-0001,Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting,Notice,Meeting,2016-07-28T04:00:00Z,2016,7,2016-07-28T04:00:00Z,,2016-07-28T13:54:07Z,2016-17864,0,0,0900006482134a01
FDA-2016-N-0001-0088,FDA,FDA-2016-N-0001,Oncologic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-07-28T04:00:00Z,2016,7,2016-07-28T04:00:00Z,,2016-07-28T14:39:03Z,2016-17865,0,0,0900006482134a4c
FDA-2016-N-0001-0086,FDA,FDA-2016-N-0001,"Vaccines and Related Biological Products Advisory Committee; Notice
of Meeting",Notice,Meeting,2016-07-27T04:00:00Z,2016,7,2016-07-27T04:00:00Z,,2016-07-27T14:24:37Z,2016-17729,0,0,0900006482129709
FDA-2016-N-0001-0085,FDA,FDA-2016-N-0001,"Advisory Committee; Science Board to the Food and Drug Administration,
Renewal",Notice,Notice of Renewal,2016-07-21T04:00:00Z,2016,7,2016-07-21T04:00:00Z,,2016-07-21T15:16:30Z,2016-17182,0,0,09000064820db935
FDA-2016-N-0001-0083,FDA,FDA-2016-N-0001,Pediatric Clinical Investigator Training Workshop; Correction,Notice,Correction,2016-07-19T04:00:00Z,2016,7,2016-07-19T04:00:00Z,,2016-07-19T14:42:45Z,2016-17015,0,0,09000064820c9ed8
FDA-2016-N-0001-0084,FDA,FDA-2016-N-0001,Pre-Clinical Evaluation of Red Blood Cells for Transfusion; Public Workshop,Notice,Public Meetings,2016-07-19T04:00:00Z,2016,7,2016-07-19T04:00:00Z,,2016-07-19T15:07:04Z,2016-17008,0,0,09000064820c9fda
FDA-2016-N-0001-0082,FDA,FDA-2016-N-0001,"Refurbishing, Reconditioning, Rebuilding, Remarketing,  Remanufacturing, and Servicing of Medical Devices Performed by Third-Party Entities and Original Equipment Manufacturers; Public Workshop",Notice,Public Meetings,2016-07-18T04:00:00Z,2016,7,2016-07-18T04:00:00Z,,2016-07-18T14:59:12Z,2016-16887,0,0,09000064820bfe05
FDA-2016-N-0001-0081,FDA,FDA-2016-N-0001,Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices; Public Workshop,Notice,Announcement,2016-07-11T04:00:00Z,2016,7,2016-07-11T04:00:00Z,,2016-07-11T12:58:25Z,2016-16353,0,0,090000648209b493
FDA-2016-N-0001-0080,FDA,FDA-2016-N-0001,"Regional Public Workshop on the International Council for  Harmonization of Technical Requirements for Pharmaceuticals for  Human Use Q3D Implementation of Guideline for Elemental Impurities;
Public Workshop",Notice,Public Meetings,2016-07-08T04:00:00Z,2016,7,2016-07-08T04:00:00Z,,2016-07-08T15:08:32Z,2016-16152,0,0,0900006482095b9d
FDA-2016-N-0001-0079,FDA,FDA-2016-N-0001,"Anesthetic and Analgesic Drug Products Advisory Committee and the
Drug Safety and Risk Management Advisory Committee; Notice of Meeting",Notice,Meeting,2016-06-29T04:00:00Z,2016,6,2016-06-29T04:00:00Z,,2016-06-29T14:07:45Z,2016-15361,0,0,09000064820787ac
FDA-2016-N-0001-0078,FDA,FDA-2016-N-0001,"Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory
Committee; Amendment of Notice",Notice,Correction,2016-06-23T04:00:00Z,2016,6,2016-06-23T04:00:00Z,,2016-06-23T14:05:49Z,2016-14827,0,0,0900006482060aeb
FDA-2016-N-0001-0077,FDA,FDA-2016-N-0001,"Bone, Reproductive and Urologic Drugs Advisory Committee; Notice 
of Meeting",Notice,Meeting,2016-06-20T04:00:00Z,2016,6,2016-06-20T04:00:00Z,,2016-06-20T12:02:53Z,2016-14418,0,0,090000648204fc9d
FDA-2016-N-0001-0076,FDA,FDA-2016-N-0001,Pediatric Clinical Investigator Training; Public Workshop,Notice,Public Meetings,2016-06-16T04:00:00Z,2016,6,2016-06-16T04:00:00Z,,2016-06-16T14:33:15Z,2016-14230,0,0,09000064820453b2
FDA-2016-N-0001-0075,FDA,FDA-2016-N-0001,"Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory 
Committee; Notice of Meeting",Notice,Meeting,2016-06-16T04:00:00Z,2016,6,2016-06-16T04:00:00Z,,2016-06-16T14:16:08Z,2016-14212,0,0,0900006482045247
FDA-2016-N-0001-0074,FDA,FDA-2016-N-0001,Menu Labeling Public Workshops; Public Meetings,Notice,Meeting,2016-06-15T04:00:00Z,2016,6,2016-06-15T04:00:00Z,,2016-06-15T15:14:48Z,2016-14138,0,0,090000648203d48f
FDA-2016-N-0001-0073,FDA,FDA-2016-N-0001,Arthritis Advisory Committee; Notice of Meeting,Notice,Meeting,2016-06-14T04:00:00Z,2016,6,2016-06-14T04:00:00Z,2016-06-28T03:59:59Z,2016-06-14T14:54:19Z,2016-14017,0,0,09000064820376ce
FDA-2016-N-0001-0070,FDA,FDA-2016-N-0001,Requests for Nominations: Individuals and Consumer Organizations for Advisory Committees,Notice,Request for Nominations,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,,2016-06-10T14:20:25Z,2016-13733,0,0,090000648202bf89
FDA-2016-N-0001-0071,FDA,FDA-2016-N-0001,Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,2016-07-06T03:59:59Z,2016-06-14T14:44:20Z,2016-13710,0,0,090000648202bfca
FDA-2016-N-0001-0072,FDA,FDA-2016-N-0001,Arthritis Advisory Committee; Notice of Meeting,Notice,Meeting,2016-06-10T04:00:00Z,2016,6,2016-06-10T04:00:00Z,2016-06-29T03:59:59Z,2016-06-29T01:00:36Z,2016-13709,0,0,090000648202bfcc
FDA-2016-N-0001-0069,FDA,FDA-2016-N-0001,Advisory Committee; Transmissible Spongiform Encephalopathies Advisory Committee; Termination,Rule,Final Rule,2016-06-09T04:00:00Z,2016,6,2016-06-09T04:00:00Z,,2016-06-09T14:38:10Z,2016-13705,0,0,0900006482025cd9
FDA-2016-N-0001-0068,FDA,FDA-2016-N-0001,"Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting",Notice,Meeting,2016-06-08T04:00:00Z,2016,6,2016-06-08T04:00:00Z,,2016-06-08T14:13:35Z,2016-13457,0,0,090000648201e546
FDA-2016-N-0001-0067,FDA,FDA-2016-N-0001,Pharmacy Compounding Advisory Committee; Notice of Meeting,Notice,Meeting,2016-06-03T04:00:00Z,2016,6,2016-06-03T04:00:00Z,,2016-06-06T19:20:20Z,2016-13169,0,0,090000648200d610
FDA-2016-N-0001-0066,FDA,FDA-2016-N-0001,"Collaborating To Strengthen Food, Drug, and Medical Device Safety
Systems; Notice of Conference",Notice,Notice of Conference,2016-06-02T04:00:00Z,2016,6,2016-06-02T04:00:00Z,,2016-06-02T13:08:13Z,2016-12942,0,0,0900006482007f3a
FDA-2016-N-0001-0065,FDA,FDA-2016-N-0001,OpenFDA Public Workshop,Notice,Public Meetings,2016-06-01T04:00:00Z,2016,6,2016-06-01T04:00:00Z,,2016-06-01T14:46:28Z,2016-12826,0,0,0900006482003ef4
FDA-2016-N-0001-0057,FDA,FDA-2016-N-0001,"Advisory Committee; Allergenic Products Advisory Committee, Renewal",Notice,Notice of Renewal,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T13:21:42Z,2016-12636,0,0,0900006481fff61f
FDA-2016-N-0001-0062,FDA,FDA-2016-N-0001,"Advisory Committee; Science Advisory Board to the National Center for
Toxicological Research; Renewal",Notice,Notice of Renewal,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T14:13:38Z,2016-12657,0,0,0900006481fff806
FDA-2016-N-0001-0058,FDA,FDA-2016-N-0001,"Facilitating Antibacterial Drug Development for Patients With Unmet
Need and Developing Antibacterial Drugs That Target a Single Species
Media; Public Workshop",Notice,Meeting,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T13:43:51Z,2016-12684,0,0,0900006481fff667
FDA-2016-N-0001-0059,FDA,FDA-2016-N-0001,Sequencing Quality Control II; Public Workshop,Notice,Public Meetings,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T13:51:43Z,2016-12656,0,0,0900006481fff6af
FDA-2016-N-0001-0061,FDA,FDA-2016-N-0001,"Advisory Committee; Psychopharmacologic Drugs Advisory Committee, Renewal",Notice,Notice of Renewal,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T14:11:30Z,2016-12637,0,0,0900006481fff73a
FDA-2016-N-0001-0063,FDA,FDA-2016-N-0001,"Clinical Trial Design Considerations for Malaria Drug Development; Notice
of Public Workshop; Correction",Notice,Correction,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T14:26:26Z,2016-12654,0,0,0900006481fff80f
FDA-2016-N-0001-0064,FDA,FDA-2016-N-0001,Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,Meeting,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T14:31:41Z,2016-12641,0,0,0900006481fff83c
FDA-2016-N-0001-0060,FDA,FDA-2016-N-0001,Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting,Notice,Meeting,2016-05-31T04:00:00Z,2016,5,2016-05-31T04:00:00Z,,2016-05-31T13:56:16Z,2016-12658,0,0,0900006481fff735
FDA-2016-N-0001-0055,FDA,FDA-2016-N-0001,Advisory Committees; Filing of Closed Meeting Reports,Notice,Notice of Filing,2016-05-20T04:00:00Z,2016,5,2016-05-20T04:00:00Z,,2016-05-20T13:47:14Z,2016-11853,0,0,0900006481fe1465
FDA-2016-N-0001-0056,FDA,FDA-2016-N-0001,Blood Products Advisory Committee; Notice of Meeting,Notice,Meeting,2016-05-20T04:00:00Z,2016,5,2016-05-20T04:00:00Z,,2016-05-20T13:50:08Z,2016-11854,0,0,0900006481fe3ab5
FDA-2016-N-0001-0054,FDA,FDA-2016-N-0001,"Diabetes Outcome Measures Beyond Hemoglobin A1c: CDER Public
Workshop",Notice,Public Meetings,2016-05-19T04:00:00Z,2016,5,2016-05-19T04:00:00Z,,2016-05-19T14:44:00Z,2016-11846,0,0,0900006481fdd08e
FDA-2016-N-0001-0053,FDA,FDA-2016-N-0001,Advisory Committee; Blood Products Advisory Committee; Renewal,Notice,Notice of Renewal,2016-05-19T04:00:00Z,2016,5,2016-05-19T04:00:00Z,,2016-05-19T14:39:11Z,2016-11774,0,0,0900006481fdd509
FDA-2016-N-0001-0052,FDA,FDA-2016-N-0001,"Advisory Committee; Drug Safety and Risk Management Advisory  Committee, Renewal",Notice,Notice of Renewal,2016-05-19T04:00:00Z,2016,5,2016-05-19T04:00:00Z,,2016-05-19T14:34:54Z,2016-11773,0,0,0900006481fdd090
FDA-2016-N-0001-0051,FDA,FDA-2016-N-0001,"Advisory Committee; Peripheral and Central Nervous System Drugs
Advisory Committee, Renewal",Notice,Notice of Renewal,2016-05-19T04:00:00Z,2016,5,2016-05-19T04:00:00Z,,2016-05-19T14:29:12Z,2016-11776,0,0,0900006481fdd00c
FDA-2016-N-0001-0050,FDA,FDA-2016-N-0001,Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-05-18T04:00:00Z,2016,5,2016-05-18T04:00:00Z,,2016-05-18T13:46:04Z,2016-11678,0,0,0900006481fda1ac
FDA-2016-N-0001-0049,FDA,FDA-2016-N-0001,"Advisory Committee; Pulmonary-Allergy Drugs Advisory Committee, Renewal",Notice,Notice of Renewal,2016-05-13T04:00:00Z,2016,5,2016-05-13T04:00:00Z,,2016-05-13T20:38:23Z,2016-11323,0,0,0900006481fcb61c
FDA-2016-N-0001-0048,FDA,FDA-2016-N-0001,"Clinical Trial Design Considerations for Malaria Drug Development Media;
Public Workshop",Notice,Public Meetings,2016-05-10T04:00:00Z,2016,5,2016-05-10T04:00:00Z,,2016-05-10T13:56:49Z,2016-10913,0,0,0900006481fbd923
FDA-2016-N-0001-0047,FDA,FDA-2016-N-0001,"Advisory Committee; Anesthetic and Analgesic Drug Products Advisory
Committee, Renewal",Notice,Notice of Renewal,2016-05-09T04:00:00Z,2016,5,2016-05-09T04:00:00Z,,2016-05-09T14:25:12Z,2016-10766,0,0,0900006481fb6e52
FDA-2016-N-0001-0046,FDA,FDA-2016-N-0001,Quantitative Assessment of Assumptions To Support Extrapolation of Efficacy in Pediatrics; Public Workshop,Notice,Public Meetings,2016-05-04T04:00:00Z,2016,5,2016-05-04T04:00:00Z,,2016-05-04T16:09:55Z,2016-10397,0,0,0900006481fa8888
FDA-2016-N-0001-0045,FDA,FDA-2016-N-0001,"Scientific Evidence in Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval; Public Workshop",Notice,Public Meetings,2016-04-22T04:00:00Z,2016,4,2016-04-22T04:00:00Z,,2016-04-22T14:01:31Z,2016-09373,0,0,0900006481f831b4
FDA-2016-N-0001-0044,FDA,FDA-2016-N-0001,Antimicrobial Drugs Advisory Committee; Notice of Meeting,Notice,Meeting,2016-04-15T04:00:00Z,2016,4,2016-04-15T04:00:00Z,,2016-04-15T15:46:50Z,2016-08637,0,0,0900006481f6c957
FDA-2016-N-0001-0043,FDA,FDA-2016-N-0001,"Circulatory System Devices Panel of the Medical Devices Advisory
Committee; Notice of Meeting",Notice,Meeting,2016-04-13T04:00:00Z,2016,4,2016-04-13T04:00:00Z,,2016-04-13T13:44:54Z,2016-08530,0,0,0900006481f647ce
FDA-2016-N-0001-0042,FDA,FDA-2016-N-0001,"Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of
Notice",Notice,Announcement,2016-04-06T04:00:00Z,2016,4,2016-04-06T04:00:00Z,,2016-04-06T14:42:32Z,2016-07906,0,0,0900006481f2e227
FDA-2016-N-0001-0040,FDA,FDA-2016-N-0001,"Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee, Renewal",Notice,Notice of Renewal,2016-04-06T04:00:00Z,2016,4,2016-04-06T04:00:00Z,,2016-04-06T14:33:36Z,2016-07908,0,0,0900006481f2e14a
FDA-2016-N-0001-0041,FDA,FDA-2016-N-0001,"Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of
Notice",Notice,Announcement,2016-04-06T04:00:00Z,2016,4,2016-04-06T04:00:00Z,,2016-04-06T14:30:46Z,2016-07899,0,0,0900006481f2e18e
FDA-2016-N-0001-0039,FDA,FDA-2016-N-0001,"Advisory Committee; Arthritis Advisory Committee, Renewal",Notice,Notice of Renewal,2016-04-01T04:00:00Z,2016,4,2016-04-01T04:00:00Z,,2016-04-01T13:32:14Z,2016-07362,0,0,0900006481f09350
FDA-2016-N-0001-0038,FDA,FDA-2016-N-0001,"Seventh Annual Predictive Safety Testing Consortium/Food and Drug
Administration Scientific Workshop; Public Workshop",Notice,Meeting,2016-03-28T04:00:00Z,2016,3,2016-03-28T04:00:00Z,,2016-03-28T13:59:15Z,2016-06889,0,0,0900006481ee3b38
FDA-2016-N-0001-0037,FDA,FDA-2016-N-0001,"2016 Parenteral Drug Association/Food and Drug Administration Joint
Conference: Aligning Manufacturing Goals With Patient Needs Through
Successful Innovation and Compliance",Notice,Notice of Conference,2016-03-22T04:00:00Z,2016,3,2016-03-22T04:00:00Z,,2016-03-22T13:23:44Z,2016-06366,0,0,0900006481ed5f3b
FDA-2016-N-0001-0036,FDA,FDA-2016-N-0001,Patient Engagement Advisory Committee,Rule,Final Rule,2016-03-21T04:00:00Z,2016,3,2016-03-21T04:00:00Z,,2016-03-21T15:13:18Z,2016-06240,0,0,0900006481ed2410